PMC7702164_01
Serum potassium changes during Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
f1000research-9-30666-g0000.jpg
PMC7702164_01_f1000research-9-30666-g0000.jpg
f1
SandoK (potassium bicarbonate and potassium chloride therapy) daily (in divided doses) and she was given 1L intravenous Hartman's solution (containing 5 mmol/L potassium) daily for three days ( Figure 1). Six days after admission the patient's oxygen requirements had returned to baseline but hypokalaemia (serum potassium 3.4 mmol/L) persisted despite treatment.